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ABSTRACT Activation of skeletal muscle ryanodine receptors (RyRs) by suramin and disulfonic stilbene derivatives
(Diisothiocyanostilbene-29,29-disulfonic acid (DIDS), 4,49-dibenzamidostilbene-2,29-disulfonic acid (DBDS),and 4,49-dinitros-
tilbene-2,29-disulfonic acid (DNDS)) was investigated using planar bilayers. One reversible and two nonreversible mechanisms
were identiﬁed. Ka for reversible activation (;100 mM) depended on cytoplasmic [Ca
21] and the bilayer composition.
Replacement of neutral lipids by negative phosphatidylserine increased Ka fourfold, suggesting that reversible binding sites are
near the bilayer surface. Suramin and the stilbene derivatives adsorbed to neutral bilayers with maximal mole fractions between
1–8% and with afﬁnities ;100 mM but did not adsorb to negative lipids. DIDS activated RyRs by two nonreversible
mechanisms, distinguishable by their disparate DIDS binding rates (105 and 60 M1 s1) and actions. Both mechanisms
activated RyRs via several jumps in open probability, indicating several DIDS binding events. The fast and slow mechanisms
are independent of each other, the reversible mechanism and ATP binding. The fast mechanism confers DIDS sensitivity
;1000-fold greater than previously reported, increases Ca21 activation and increases Ki for Ca
21/Mg21 inhibition 10-fold. The
slow mechanism activates RyRs in the absence of Ca21 and ATP, increases ATP activation without altering Ka, and slightly
increases activity at pH \ 6.5. These ﬁndings explain how different types of DIDS activation are observed under different
conditions.
INTRODUCTION
Muscle function, is regulated by the release of calcium from
the internal stores. In striated muscle this occurs via calcium
release channels (ryanodine receptors (RyRs)) in the sarco-
plasmic reticulum (SR). Modulation of RyR function by
constituents of the cytoplasm and SR lumen, such as
ATP, Ca21, Mg21, and pH, is central to their role in muscle
contraction (Coronado et al., 1994; Meissner, 1994). There
are several isoforms of the RyR. In mammals, three isoforms
of RyRs have been cloned and sequenced: RyR-1 (skeletal
muscle), RyR-2 (cardiac muscle) and RyR-3 (numerous cell
types). In amphibian, ﬁsh, and avian muscle, two isoforms
have been sequenced (RyR-a and RyR-b), which are similar
to RyR-1 and RyR-3, respectively (Sutko and Airey, 1996).
One isoform has been identiﬁed in Caenorhabditis elegans
(Hamada et al., 2002).
Disulfonic stilbene derivatives have been extensively used
as pharmacological probes to study the transport kinetics and
molecular structure of a wide range of membrane trans-
porters. Excellent examples of this include the elucidation of
the double-barreled structure of ClC0 (Miller and White,
1984), the transport kinetics and structure of the band-3
anion transporter (Knauf, 1979) and structure of the ATP
binding site of the SR CaATPase (Hua and Inesi, 1997). In
muscle, diisothiocyanostilbene-29,29-disulfonic acid (DIDS)
has been widely used to understand the role, and mechanism,
of various ion transport processes in the sarcolemma and the
membranes of internal organelles such as the SR.
Disulfonic stilbene derivatives are known to activate and
inhibit ion channels and transporters by both reversible and
nonreversible mechanisms. Nonreversible effects are due to
the isothiocyanate groups which form covalent bonds with
a variety of amino acid residues by reacting with NH2 groups
on lysine residues, OH groups on serine residues, and
aromatic groups on tyrosine and cysteine residues. DIDS has
two isothiocyanate groups and 49-acetamido-49-isothiocya-
nostilbene-29,29-disulfonic acid (SITS) only has one of these
groups (Fig. 1). 4,49-Dibenzamidostilbene-2,29-disulfonic
acid (DBDS), and 4,49-dinitrostilbene-2,29-disulfonic acid
(DNDS) both lack isothiocyanate groups and so cannot form
covalent bonds with amino acids. Given the promiscuous
nature of disulfonic stilbene derivatives, it is not surprising
that they also affect the calcium release channels in muscle
(Hill and Sitsapesan, 2002; Kawasaki and Kasai, 1989; Oba
et al., 1996; Sitsapesan, 1999; Zahradnikova and Zahradnik,
1993).
Kawasaki and Kasai (1989) were the ﬁrst to report that
DIDS and SITS activate RyR-1 from rabbit skeletal muscle
in both SR vesicles and lipid bilayers. They found that these
compounds locked RyRs in to an open state with a Ba21
conductance not signiﬁcantly different to native RyRs. They
could discern reversible and nonreversible effects of DIDS
in Ca21 release measurements by the fact that reversible
activation occurred more rapidly than nonreversible activa-
tion. Zahradnikova and Zahradnik (1993) were the ﬁrst to
report that DIDS had a similar activating effect on RyR-2
from dog heart while using Cs1 as the conducting ion.
Investigations of the effect of DIDS on RyR-a from frog
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muscle revealed that DIDS modiﬁed RyRs could still be
regulated by Mg21, ruthenium red, and ryanodine (Oba et al.
1996). However, it was not until recently that the ﬁrst
investigation of reversible and nonreversible effects of DIDS
on RyR-2 was published (Sitsapesan, 1999). DIDS also
causes a 20% increase in the Ca21 conductance of the RyRs
although only producing 8% increase in K1 conductance
(Hill and Sitsapesan, 2002) and no signiﬁcant change in Cs1
conductance (Oba et al., 1996; Zahradnikova and Zahradnik,
1993).
Suramin (1,3,5-naphthylenetrisulfonic acid) is a trypano-
cide which acts as an ATP antagonist for P2-purinoceptors
(Dunn and Blakeley, 1988; Kennedy, 1990). Although
suramin is a strong activator of RyRs, it regulates RyRs via
a site that is distinct from its adenine nucleotide binding sites
(Hohenegger et al., 1996; Sitsapesan and Williams, 1996).
Similarities in the structures of suramin and DIDS and their
effects on RyR function suggest that these compounds may
share a common mode of action on RyRs (Sitsapesan, 1999).
The manifold effects of disulfonic stilbene derivatives and
suramin on RyRs make these compounds potentially useful
probes for elucidating the mechanisms of RyR function. Two
studies have already used these compounds to probe the
inactivation properties of RyRs (Hill and Sitsapesan, 2002)
and interactions between RyRs and their coproteins,
calmodulin (Klinger et al., 2001) and the 30-kDa protein
(Hirata et al., 1999). Moreover, efforts have been made to
identify high afﬁnity suramin analogs that may ultimately
lead to therapies based on modifying RyR function in vivo
(Klinger et al., 1999). Despite the burgeoning interest in
DIDS and suramin analogs, the mechanisms underlying their
reversible and nonreversible activation of RyRs are largely
unknown. Furthermore, it is not known how disulfonic
stilbene derivatives modify the way RyRs are regulated
by physiologically important ligands. This paper describes
a detailed investigation of the mechanisms of RyR activation
by suramin and the disulfonic stilbene derivatives, DIDS,
DBDS, and DNDS, and how these compounds modify RyR
regulation by ATP, Ca21, Mg21, and pH. The effects of
these compounds were measured from recordings of RyR
activity in lipid bilayers. Experiments were greatly improved
by the use of a relatively fast, local perfusion technique to
apply and withdraw modifying agents. This permitted higher
time resolution of the RyR activation time course than
previously achieved using the aliquot addition methods. This
approach revealed two independent mechanisms for non-
reversible activation by DIDS which affect RyR function in
different ways.
MATERIALS AND METHODS
Preparation of SR microsomes
SR vesicles were prepared from the back and leg muscles of New Zealand
rabbits killed by captive bolt before muscle removal. The procedure was
carried out by the holder of a current license granted under ACT State
legislation. Native SR vesicles were isolated using techniques based on Chu
et al. (1988), as previously described by Laver et al. (1995).
Lipid bilayers, chemicals, and solutions
Unless otherwise stated, lipid bilayers were formed from phosphatidyleth-
anolamine (PE) and phosphatidylcholine (PC) (8:2) (Avanti Polar Lipids,
Alabaster, Alabama) dissolved in 20 ml n-decane (50 mg/ml). In some
experiments bilayers were formed from phosphatidylserine (PS), which
possesses a negative charge on its polar headgroup. The bilayers were
formed across an aperture of 100–200 mm diameter in a Delrin cup. The
bilayer separated two solutions: cis and trans (;1 ml). Vesicles were added
to the cis solution and vesicle incorporation with the bilayer occurred as
described by Miller and Racker (1976). Due to the orientation of RyRs in the
SR vesicles, RyRs added to the cis chamber incorporated into the bilayer
with the cytoplasmic face of the channel orientated to the cis solution. In
a minority of experiments SR vesicles were subject to several freeze-thaw
cycles before use to produce larger vesicle sizes. Vesicles were snap frozen
in liquid N2 and thawed at room temperature. RyRs treated this way were
the same as native RyRs in regard to their regulation by Ca21, Mg21, ATP,
and pH.
During SR vesicle incorporation the cis (cytoplasmic) solution contained
250 mM Cs1 (230 mM CsCH3O3S, 20 mM CsCl) with 1.0 or 0.1 mM
CaCl2, and the trans (luminal) solution contained 50 mM Cs
1 (30 mM
CsCH3O3S, 20 mM CsCl), and 0–1.0 mM CaCl2. The osmotic gradient
FIGURE 1 Structural formulae of the commonly used
disulfonic stilbene derivatives.
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across the membrane and the Ca21 in the cis solution also aided vesicle
fusion with the bilayer. The cesium salts were obtained from Aldrich
Chemical Company and CaCl2 from BDH Chemicals. Unless otherwise
stated, solutions were pH buffered with 10mM N-tris[Hydroxymethyl]-
methyl-2-aminoethanesulfonic acid (TES, obtained from ICN Biomedicals)
and solutions were titrated to pH 7.4 using CsOH (optical grade from ICN
Biomedicals).
The required free [Ca21] was attained by buffering with 4.5 mM BAPTA
(1,2-bis(o-aminophenoxy)ethane-N,N,N9,N9-tetraacetic acid, obtained as
a tetrapotassium salt from Molecular Probes) and titrated with CaCl2. Free
[Ca21] in excess of 0.1 mM was measured using a Ca21 electrode (Fluka).
At lower concentrations, free [Ca21] was estimated using published
association constants (Marks and Maxﬁeld, 1991) and the program ‘‘Bound
and Determined’’ (Brooks and Storey, 1992). Solutions, which mimicked
zero Ca21, were made with 4.5 mM BAPTA and no added Ca21. In these
solutions the total [Ca21] arising from impurities was measured to be 15 mM
so that with addition of 4.5 mMBAPTA the free [Ca21] was calculated to be
1 nM. Adenosine 59-triphosphate (ATP) and adenosine were obtained in the
form of sodium salts from Sigma Chemicals. Unless otherwise stated, DIDS,
DBDS, DNDS, and suramin (sodium salts) were prepared as stock solutions
in DMSO (dimethyl sulfoxide) at concentrations between 5–50 mM. DIDS,
suramin, and DMSO were obtained from ICN Biomedicals and DBDS and
DNDS from Molecular Probes. Care was taken to insure that DMSO in the
bath solutions did not exceed 1% because DMSO concentrations above 2%
inhibited RyR activity (see Results).
Solution changes
During experiments the composition of the cis solution was altered either by
addition of aliquots of stock solutions or by perfusion of the bath near the
bilayer. The local perfusion method allowed solution exchange, in ;1 s,
between twelve available solutions in random sequence. A 10-fold speed
improvement on our previously described apparatus (Laver et al., 2000) was
achieved using a ﬁner micro manifold (a generous gift from ALA Scientiﬁc
Instruments, 1100 Shames Drive, Westbury, NY 11590). Desired ﬂow rates
were achieved using a pressure driven syringe injection system (produced
in-house). The perfusion system allowed convenient addition and removal of
drugs, improved the time resolution in the channel activation experiments
and permitted accurate measurement of solution composition.
Data acquisition and analysis
Bilayer potential was controlled and currents recorded using an Axopatch
200B ampliﬁer (Axon Instruments). The cis chamber was electrically
grounded to prevent electrical interference from the perfusion tubes, and the
potential of the trans chamber was varied. However, all electrical potentials
are expressed here using standard physiological convention (i.e., cytoplas-
mic side relative to the luminal side at virtual ground). Single channel
recordings were obtained using a bilayer potential difference of 140 mV.
During the experiments the channel current was recorded after low pass
ﬁltering at 5 kHz and sampling at 50 kHz. The data were stored on computer
disk using a data interface (Data Translation DT301) under the control of in-
house software written in Visual Basic. For measurements of unitary current
andPo, the current signal was digitally ﬁltered at 1 kHz with a Gaussian ﬁlter
and sampled at 5 kHz. Unitary current and time-averaged currents were
measured using Channel2 software (P.W. Gage and M. Smith, Australian
National University, Canberra). To calculate Po from single channel records,
a threshold discriminator was set at 50% of channel amplitude to detect
channel opening and closing events. For experiments in which bilayers
contained several RyRs, the time-averaged current was divided by the
unitary current and the number of channels. The number of channels in each
experiment could be determined during periods of strong activation. In
experiments where suramin or stilbene derivatives were poor activators,
ATP was used to activate channels for counting. Both methods of calculating
Po gave similar results. Frequency histograms of dwell-time durations were
compiled from channel records ﬁltered at 5 kHz and sampled at 50 kHz.
Event durations were extracted from the data using 50% threshold detection
which, in conjunction with the ﬁltering, had a dead time of ;40 ms. The
histograms are presented as probability distributions using variable bin
widths with equal separation on a log scale as described by Sigworth and
Sine (1987).
Statistics and curve ﬁtting
Unless otherwise stated the data are presented as mean 6 standard error on
the mean (SEM). Theoretical curves were ﬁtted to the data using the criteria
of least squares. The open probability (Po) of RyRs, activated or inhibited by
a compound with concentration c was ﬁtted by Hill equations, Eqs. 1 and 2,
respectively:
Po ¼ Pi1 ðPmax  PiÞð11ðKa=cÞnaÞ ; (1)
Po ¼ Pmaxð11ðc=KiÞniÞ ; (2)
where Pi and Pmax are RyR open probabilities in the absence of drug and at
maximal activation, respectively.Ka andKi are half activation and inhibition
concentrations and na and ni are the corresponding Hill coefﬁcients. The
magnitude of activation produced by two compounds (noted by subscripts in
Eq. 3) that act at a common site is given by:
Po ¼ Pmaxð1Þðc1=Ka1Þ
n11Pmaxð2Þðc2=Ka2Þn2
11ðc1=Ka1Þn11ðc2=Ka2Þn2 : (3)
Analysis of adsorption of suramin, DIDS analogs
to lipid bilayers
The method for measuring changes in bilayer surface potential and the
binding constants for DIDS and its analogs is similar to that used to
previously to measure the binding of cations to lipid bilayers (Laver and
Curtis, 1996). The change in surface potential DV that drives the capacitive
current I can be calculated from the bilayer capacitance, C, by Eq. 4.
DV ¼ 1
C
ð t
0
I dt; (4)
where t is the duration of the current transient. Ca21 and Cs1 can bind
competitively with PS headgroups in the bilayer and Ca21 and DIDS bind
competitively with the neutral lipids. Although Ca21 binds to lipids with 1:1
stoichiometry (McLaughlin et al., 1978; McLaughlin et al., 1981), DIDS
only binds to a fraction F of the neutral lipid headgroups. The Stern equation
(Eq. 5) relates the surface charge density s to the bilayer and bath
composition.
s ¼ P
½1 K2Ca21ð0Þ
½11K1Cs1ð0Þ1K2Ca21ð0Þ
1
2FP½K3Ca21ð0Þ  K4DIDS2ð0Þ
½11K3Ca21ð0Þ1K4DIDS2ð0Þ
1
2½1 FPK3Ca21ð0Þ
½11K3Ca21ð0Þ ; (5)
where
Ca21ð0Þ ¼ Ca21ð‘Þ3 exp½2eco=RT (6)
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Cs1ð0Þ ¼ Cs1ð‘Þ3 exp½eco=RT (7)
DIDS2ð0Þ ¼ DIDS2ð‘Þ3 exp½2eco=RT: (8)
Eqs. 6–8 relate the bulk ionic concentrations, Ca21(‘), Cs1(‘), and
DIDS2(‘) with their concentrations at the bilayer surface, Ca21(0),
Cs1(0), and DIDS2(0). P and P are the concentrations of negatively
charged lipids (PS) and zwitterionic lipids (PC and PE), respectively. K1 to
K4 are the association constants for the following molecular pairs: K1 (Cs
1
and PS), K2 (Ca
21 and PS), K3 (Ca
21 and PE or PC), and K4 (DIDS and PE
or PC). The ﬁrst term in Eq. 5 predicts the surface charge arising from the
binding of Ca21 to PS in competition with Cs1. The second term predicts the
charge from competitive binding of DIDS and Ca21 to the fraction F of PE
or PC headgroups. The last term shows the charge contribution from Ca21
binding to the fraction of neutral lipids that do not bind DIDS.
Mobile ions in the bath screen the bilayer surface charge and affect the
surface potential co. The Grahame equation (Eq. 9, Grahame, 1947) relates
the surface charge density to the surface potential.
s ¼ 6 2ereoRT+
i
Ci½expðziFco=RTÞ  1
 1=2
: (9)
RESULTS
Adsorption of DIDS analogs and suramin
to lipid bilayers
The molecular structures of these compounds are shown in
Fig. 1. Rapid application and removal of DIDS, DBDS,
DNDS, and suramin to lipid bilayers elicited transient
currents through the bilayer as shown in Fig. 2 A. The
transients were generally ﬂatter and broader during washout
than during application. The magnitude of the transient
FIGURE 2 Changes in bilayer surface potential upon rapid application and removal of DIDS analogs and suramin. (A) Current transients produced by rapid
DIDS application (downward) followed by removal (upward). When DIDS solutions came in contact with the bilayer the current departed from its steady
baseline (dashed line) and returned to baseline levels after complete solution exchange had occurred. The two downward spikes preceding each transient marks
the time that the solenoid valves switched solution ﬂow. (B) The size of the transient current depended on the DIDS concentration and the lipid composition of
the bilayer. Trace 1 shows the relatively weak transient in response to 500 mM DIDS applied to PS bilayers. Traces 2–5 show current transients through PE
bilayers in response to DIDS concentrations of 50 mM, 100 mM, 200 mM, and 500 mM, respectively. (C) The change in bilayer surface potential caused by
DIDS absorption to the bilayer. The surface potential changes on bilayers formed from neutral lipids (PE) are much larger than those seen with negatively
charged PS bilayers. This indicates that DIDS preferentially adsorbs to the neutral lipids. (D) The surface potentials generated by adsorption of DIDS, DBDS,
DNDS and suramin to bilayers composed of PE and PC (80:20). There was no signiﬁcant difference in the adsorption of DIDS to the bilayer at 1 nM and 1 mM
cytoplasmic Ca21. The curves show ﬁts of the Stern and Grahame equations to the data (Eqs. 5–9). The parameters used to ﬁt the data are given in Table 1.
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current increased with increasing [DIDS] in the perfusing
solution and also depended on the lipid composition of the
bilayer (Fig. 2 B). DIDS application to bilayers composed of
zwitterionic lipids (i.e., net neutral) such as PE and PC
produced transients as shown in Fig. 2 B (traces 2–5).
However, when bilayers were formed from negatively
charged lipids, the current transients were either very small
or absent (trace 1). These transients are similar to those seen
in previous bilayer experiments where the phenomenon was
shown to be due to a change in the bilayer surface potential
(Laver and Curtis, 1996). The magnitude of the surface
potential depended on the bilayer surface charge (i.e., the
charge arising from the lipid headgroups and ions adsorbed
from the bath) and the screening of this charge by mobile
ions in the bath. Changes in bilayer surface potential were
accurately predicted by the Gouy-Chapman-Stern theory and
the known afﬁnities for cation binding to lipid headgroups.
Thus, it is likely that the current transients observed here are
due to the adsorption of the DIDS molecules to the bilayer
surface. The broader transient associated with DIDS removal
could reﬂect a relatively slow desorption of DIDS from the
bilayer. However, we can not rule out the possibility that
these differences stem from different rates of application and
washout.
Changes in the bilayer surface potential DV caused by
the application and removal of DIDS and suramin were
measured from the capacitive current and compared with the
predictions of Gouy-Chapman-Stern theory in Fig. 2, C and
D (Eqs. 4–9, see Materials and Methods). Generally, DV
calculated from DIDS washout was 80% 6 10% (six sets of
experiments) of that during application and the averages of
the values are shown in Fig. 2. The theory was ﬁtted using
only two variable parameters; namely, the mole fraction
of the neutral lipids that can bind suramin and DIDS ana-
logs (F) and their binding afﬁnities (K4, see Table 1). The
binding afﬁnities for Ca21 and Cs1 (K1, K2, and K3) have
been determined independently from electrophoresis studies
(McLaughlin et al., 1981) and these are given in the caption
to Table 1. This analysis shows that DIDS and its analogs
bind, on average, to 1–8% of the neutral lipids with binding
afﬁnities of the order of 100 mM (see Table 1). DIDS did not
bind as strongly to bilayers containing 50% negatively
charged PS and showed no detectable binding to bilayers
composed of entirely of PS. Incorporation of 50% PS into
lipid bilayers did not signiﬁcantly alter the fraction of neutral
lipids that were available for DIDS binding.
Effects of suramin, DIDS, DBDS, DNDS,
and DMSO on RyRs
Once vesicles were added to the cis bath, the fusion of RyRs
with the bilayer ensued in 5–10 min. The number of RyRs
incorporated with the bilayer with any particular vesicle
fusion event varied enormously from one fusion to the next
and appeared to follow a bimodal distribution. Most fusion
events incorporated either a few (1 or 2) or many RyRs (10–
30). This bimodal nature of RyR incorporation proved very
useful because single channel properties could be readily
measured during experiments involving single RyR incor-
porations whereas multiple channel incorporations allowed
a convenient and rapid bulk assay for RyR activity. As seen
in previous studies on cardiac RyRs (Sitsapesan, 1999),
DIDS added to the cytoplasmic side of the bilayer activates
RyRs by both reversible and nonreversible mechanisms
which are both apparent in Fig. 3 A. Also consistent with
previous studies we found that suramin and DIDS analogs
(DNDS and DBDS) that lacked the isothiocyanate moieties
could reversibly activate RyRs but showed no signiﬁcant
nonreversible effects on RyR activity (e.g., Fig. 3 D). These
compounds had no signiﬁcant effect on the Cs1 conductance
of RyRs. The conductance of RyRs in the presence of 500
mMDIDS ([Ca21]¼ 1/0 mM cis/trans) was equal to 0.996
0.01 (n ¼ 5) of control in neutral bilayers and 0.97 6 0.05
(n ¼ 4) in PS bilayers.
The relatively fast solution exchange method employed in
these experiments revealed novel features in the reversible
and nonreversible DIDS activation mechanisms. In bilayers
formed from neutral lipids, skeletal RyRs were strongly and
rapidly activated in the presence of 500 mM DIDS. The
recordings in Fig. 3, A and B and other single channel
recordings (n ¼ 8, not shown) indicate that RyRs are
activated to Po ; 1 in the presence of DIDS. In the near
absence of free Ca21 (;1 nM) short exposures to DIDS
produced activation that was mainly reversible. However,
a clear nonreversible effect of DIDS slowly accumulated in
the RyR population during long exposures (Fig. 3 A). In the
presence of 1 mM Ca21 (Fig. 3 B) the immediate activation
of RyRs by 500 mM DIDS was similar to that seen in the
absence of Ca21. However, even after very short DIDS
exposures the nonreversible effect of DIDS was relatively
large indicating that nonreversible activation occurs much
more rapidly in the presence of Ca21 than in its absence.
TABLE 1 Binding constants for stilbenes to lipid bilayers
Row F (PE) K4, m
3/mole Afﬁnity, mM
1 DIDS 0.07 6 0.01 3 6 1 330 6 110
F (PE:PC) (80:20)
2 DIDS 0.077 6 0.010 5 6 2 200 6 80
3 DBDS 0.03 6 0.02 5 6 2 200 6 80
4 DNDS 0.020 6 0.003 1.5 6 0.3 660 6 130
5 suramin 0.013 6 0.003 10 6 5 100 6 50
F (PS:PE) (50:50)
6 DIDS 0.08 6 0.02 3 6 1 330 6 110
The variable parameters in Eqs. 5–9 used to ﬁt the data in Fig. 2 C (rows 1
& 6) and D (rows 2–5). The other parameters used in the ﬁts were
determined by (McLaughlin et al., 1981). These are: (m3/mole) K1 ¼ 5 3
105, K2 ¼ 1.2 3 102, K3 ¼ 3 3 103. Lipid concentrations P and P
(mole/m2) are calculated from the lipid weight fraction multiplied by 2.383
106.
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Given that negative charge on the PS headgroups
abolished adsorption of DIDS to the bilayer surface it was
of interest to see if RyRs residing in bilayers composed of PS
responded differently to DIDS. Fig. 3 C shows an example
of 5 experiments showing the effect of DIDS on many RyRs
in a PS bilayer in 1 mMCa21. Comparison of Fig. 3, B andC
shows that DIDS produced less activation in PS bilayers than
in neutral bilayers. This difference is shown again in single
channel records in Fig. 4, A and B The reduced activation in
the presence of PS is due to its effect on reversible activation
because it also reduced RyR activation by suramin (Fig. 4, C
and D, and see below).
DMSO had a pronounced inhibitory effect on RyRs at
concentrations in excess of 2% (4 experiments on 12
channels). The Po of RyRs, relative to control, in the
presence of 1mMCa21 and either suramin or ATP was 1.16
0.13 in 2% DMSO, 0.71 6 0.05 in 3% DMSO and 0.56 6
0.09 in 4% DMSO.
Reversible activation in bilayers of neutral and
negative lipids
The reversible effects of stilbene derivatives were most
easily studied using suramin, DBDS, and DNDS, which did
not produce additional nonreversible activation of RyRs. The
concentration dependencies of RyR activation by these
compounds in the presence of 1 mM cytoplasmic Ca21 are
shown in Fig. 5 A, B, and D, and the Hill ﬁt parameters are
summarized in Table 2. Suramin and DBDS activated RyRs
to a Po in excess of 0.8 whereas DNDS could only produce
a Po of 0.31. The concentration dependence of the reversible
effect of DIDS (Fig. 5 C) was more difﬁcult to measure due
to the onset of nonreversible activation. This problem was
alleviated to a large extent by doing experiments in low
[Ca21] with bilayers containing large numbers of RyRs so
that reliable estimates of mean channel activity could be
made over short time intervals. Nonreversible activation by
DIDS is relatively slow in the absence of Ca21 (e.g., see
Figs. 3 A and 6 A), which kept the level of nonreversible
activation to less than 10% (i.e., Po ; 0.1) during these
experiments. The apparent afﬁnities of these compounds for
RyRs follow the sequence: suramin (47 mM)[DBDS (151
mM)[DNDS (714 mM). The Hill coefﬁcients of activation
exceeded 1 (na ; 2) which indicates that the binding of two
or more molecules is involved in RyR activation. The
concentration dependencies of suramin activation in bilayers
composed of negatively charged lipids are compared with
neutral lipids in Fig. 5, A and D. Bilayers composed of PS
FIGURE 3 The reversible and nonreversible effects of DIDS and
suramin on RyRs in neutral (PE and PC) and charged (PS) bilayers.
(A) Nine RyRs in a neutral bilayer in the presence of ;1 nM
cytoplasmic Ca21 (4.5 mM BAPTA plus 15 mM Ca21 impurity).
Cis addition of 500 mM DIDS (bars) strongly activated all the
channels to Po; 1. Washout of DIDS after a 10 s exposure reversed
most of the DIDS induced activation. However, subsequent longer
exposures (20 s, 30 s, and 60 s) resulted in substantial nonreversible
activation of RyRs (n ¼ 8). (B) Similar experiment as A except
the cytoplasmic bath contained 1 mM Ca21. In this experiment 7
RyRs showed strong activation by 500 mM DIDS. However, in
the presence of 1 mM Ca21, a 5 s exposure to DIDS resulted in
activation that was mainly nonreversible (n ¼ 10). (C) Approxi-
mately 20 RyRs in a PS bilayer in the presence of 1 mM cytoplasmic
Ca21. Again, 500 mM DIDS activated RyRs but the activation
was not as complete as seen in parts A and B. Like part B, the
nonreversible effect of DIDS was relatively large compared to
that seen during similar DIDS exposures in A (n ¼ 5). (D)
Approximately 20 RyRs in the presence of 1 mM Ca21 exposed
to 1 mM suramin for the duration of the bar. The effect of suramin
was totally reversible. (A–D) Bilayers were held at 140 mV. The
current baselines are shown by the dashed lines and approximate
scales for mean open probability (Po) of the RyRs at the right of each
panel. Drug addition and washout was done using local perfusion,
which in these experiments exchanged solutions at the bilayer sur-
face in less than 2 s.
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(Fig. 5 D) signiﬁcantly reduced the effects of suramin and
DBDS. In the case of suramin, this occurred mainly by via
a 350% reduction in apparent afﬁnity (160 mM compared
with 47 mM in neutral lipids; see Table 2). Thus membrane
composition is an important consideration when comparing
data obtained from bilayers studies with data obtained from
native SRwhich is low in PS (3–4% PS; Krainev et al., 1995).
Reversible activation at high and low [Ca21]
Previous studies have shown that the apparent afﬁnity of
suramin for RyRs is enhanced by the presence of
cytoplasmic Ca21 (Hohenegger et al., 1996; Klinger et al.,
1999; Suko et al., 2001). Inasmuch as suramin and DIDS
analogs might share common reversible binding sites
(Sitsapesan, 1999), we tested the possibility that reversible
binding of DIDS and DBDS were also Ca21 dependent. The
data in Fig. 5, A and C show that this is indeed the case.
The concentration dependence of DBDS activation in the
presence and absence of Ca21 are distinctly different. In the
absence of Ca21, RyRs are less activated by DBDS and do
so with a weaker apparent afﬁnity (320 mM compared with
151 mM in 1 mM Ca21, see Table 2).
Competition experiments
with reversible activation
The question of whether suramin activates RyRs by binding
to the adenine nucleotide site on RyRs has been addressed
previously by measuring the additive effects of ATP
and suramin on RyR activation (Hohenegger et al., 1996;
Sitsapesan and Williams, 1996). Here we apply another test
for this hypothesis where we examine effect of adenosine on
suramin activated RyRs. Adenosine is a weak RyR agonist
that inhibits ATP activated RyRs by competing with ATP for
the activating sites on the RyR. If suramin and ATP activate
RyRs by the same mechanism, then adenosine should also
act as an inhibitor of suramin activated RyRs. We found that
the opposite was the case. Before adenosine addition, RyRs
in the presence of 0.1 mM Ca21 (Po ¼ 0) were activated by
the addition of 100 mM suramin to a mean Po ¼ 0.07
(average of 8 channels in 2 experiments). Addition of 5 mM
adenosine further activated RyRs to a Po of 0.26. Therefore,
in accord with conclusions of previous studies, suramin
activates RyR at a set of sites that are distinct from the ATP
activation sites.
We were unable to resolve competitive inhibition by
DNDS of suramin activated RyRs. In 3 experiments on 16
channels, 2 mM DNDS reduced the Po of suramin activated
RyRs to 0.97 6 0.08 (i.e., no signiﬁcant effect). However,
given the values of Ka and Pmax for channel activation
(Table 2), the inhibiting effect of DNDS is not likely to be
larger than 15% (see Eq. 3).
Nonreversible activation in the presence
and absence of Ca21
DIDS produced nonreversible activation of RyRs in both the
absence and presence of cytoplasmic Ca21. However, the
rate constants for activation varied enormously with [Ca21];
being 3 orders of magnitude larger in the presence of acti-
vating [Ca21] ([1 mM) than in its absence (;1 nM). The
DIDS activation rates at low and high Ca21 were so dis-
parate that it was necessary to measure them using different
[DIDS]; 500 mM in the absence of Ca21 and 1 mM in the
presence of Ca21. Fig. 6 A shows the activation of RyRs
at two extremes of [Ca21] in the presence of 500 mM DIDS.
To distinguish nonreversible activation from the reversible
effects of DIDS at these high concentrations it was necessary
FIGURE 4 Representative recordings of the effect of bilayer lipid charge
on the activation of single RyRs by DIDS and suramin. (A and B) RyR
activity in bilayers composed of negative PS (n ¼ 5) and neutral PE:PC
(80%:20%, n ¼ 8) before and during exposure to 500 mM DIDS (bar).
(C and D) Similar bilayers with RyRs continuously exposed to 200 mM
suramin (n ¼ 10 for PS, n ¼ 10 for PE:PC). Channel openings are upward
current transitions from the baseline (dashed lines). RyR activation was
more pronounced in bilayers composed of neutral lipids. Note the current
transient associated with DIDS adsorption to neutral lipids in B which is
absent from bilayers composed of PS lipids in A. Bilayers were held at140
mV and cis [Ca21] ¼ 1 mM.
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to wash away the DIDS solution before each measurement of
RyR activity. The experimental protocol used for this is the
same as that used to produce the multi-channel recording in
Fig. 3 A. RyR activation obtained in this way followed an
exponential dependence on DIDS exposure time with a
time constant of 48 6 13 s that corresponds to an appa-
rent binding rate constant of ;60 M1 s1. The same
experiments carried out in the presence of 10 mM Ca21 pro-
produced much faster activation. Although exponential ﬁts to
the activation time course had a time constant of 12 6 6 s, it
is likely that this value is strongly affected by the rate of
solution exchange. A more accurate measure of the activa-
tion rate in high [Ca21] was achieved by adding much lower
DIDS concentrations (1 mM) to the bath (see Fig. 6 B). In
the presence of 100 mMCa21, 1 mMDIDS produced half ac-
tivation of RyRs in 23 6 3 s (4 experiments on 60 RyRs)
which gives an apparent binding rate constant of ;105 M1
s1 (cf. 60 M1 s1 in the absence of Ca21). The time course
of activation was strongly sigmoidal. In all experiments there
was a substantial latency that was far too long to be attributed
to the time for solution exchange.
The different DIDS activation rates seen in the presence
and absence of Ca21 could be due to the combined effect of
two independent mechanisms (fast and slow) that affect RyR
activity over different [Ca21] ranges or alternatively, due to
the Ca21 dependence of DIDS binding per se. To investigate
this further we carried out two sets of experiments. In the
ﬁrst set we measured DIDS induced activation at 3 mM
Ca21 (this is approximately equal to the half-activating con-
centration for Ca21, see Fig. 9 A) to see if fast and slow
activation mechanisms could be discerned at a given [Ca21].
Three experiments (two multi- and one single-channel
recording) were carried out as shown by the example in
Fig. 6 C. After control recordings were obtained at 3 mM
Ca21, RyRs were rapidly activated by 10 mM DIDS and
channel activity reached a relatively steady level after ;2 s.
After a minute the RyRs were exposed for;30 s to 500 mM
DIDS after which [DIDS] was returned to 10 mM. In
all cases, transient exposure to 500 mM DIDS irreversibly
activated RyRs by another twofold. This indicates that a slow
DIDS binding process was operating in addition to a fast
DIDS binding mechanism.
In the second set of experiments we exposed RyRs to
DIDS at one Ca21 concentration and measured the degree of
FIGURE 5 The reversible effects of DIDS,
DBDS, DNDS, and suramin, on the open
probability of RyRs. (A) Activation of RyRs by
DBDS (4, 23) or suramin (10,175) in neutral
bilayers, in the presence of 1 mM cytoplasmic
Ca21. (B) DNDS activation of RyRs (4, 30)
in neutral bilayers in the presence of 1 mM
cytoplasmic Ca21. (C) Activation of RyRs by
DBDS (3, 18) and DIDS (4, 62) in neutral
bilayers in the absence of Ca21. For the DIDS
experiments short exposure times (;5 s) were
used so that the activation was largely due to
the reversible effects of DIDS (nonreversible
activation by DIDS is relatively slow in the
absence of Ca21, e.g., see Figs. 3 A and 6 A).
The relative size of the nonreversible effects
can be seen here in Po values at zero [DIDS].
(D) Activation of RyRs by suramin (10, 124)
and DBDS (4, 16) in bilayers composed of PS
in the presence of 1 mM Ca21. In bilayers
composed of negatively charged PS, suramin
and DBDS are much weaker activators of the
RyR. The curves show ﬁts of Po to the Hill
equation (Eq. 1). The parameters of the ﬁts are
given in Table 2. The data points show the
means of several experiments, which were
mostly carried out on multiple RyRs. Numbers
in parentheses represent the numbers of
channels and experiments, respectively.
TABLE 2 Hill-ﬁt parameters for stilbene activation
Pmax Pi Ka, mM na
Suramin 0.83 6 0.07 0.03 6 0.05 47 6 8 1.7 6 0.5
Suramin (PS) 0.50 6 0.05 0.14 6 .05 160 6 30 3.0 6 1.0
DNDS 0.31 6 0.03 0.08 6 0.02 714 6 110 2.2 6 0.6
DBDS 0.89 6 0.07 0.05 6 0.03 151 6 16 1.6 6 0.5
DBDS (1 nM Ca21) 0.55 6 0.13 0 6 0.001 320 6 80 2.2 6 0.6
DIDS (1 nM Ca21) 0.77 6 0.10 0.08 6 0.05 170 6 35 4.0 6 2.0
The parameter values used to ﬁt the data in Fig. 5A, C, and D (see Eqs. 1
and 2). Unless otherwise stated the effects of these compounds were
measured in neutral bilayers in the presence of 1 mM cytoplasmic Ca21.
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RyR activation at a different Ca21 concentration. In one set
of experiments RyRs were exposed to 1 mMDIDS for;20 s
in the presence of 1 nM Ca21. DIDS was then washed away
and [Ca21] was raised to 100 mM. One example, typical of
four experiments is shown in Fig. 6 D. RyRs were found to
be activated to the same degree as would have been achieved
if they had been exposed to DIDS in the presence of Ca21. In
converse experiments, (n ¼ 4, not shown) RyRs were
incubated with DIDS in the presence of 100 mM Ca21 and
their activity was measured in the absence of Ca21. These
channels required long exposures to 500 mM DIDS to
show any signiﬁcant activation once DIDS and Ca21 were
removed. Thus the DIDS effects depend on [Ca21] during
the measurement rather than on [Ca21] during DIDS
incubation. This indicates that the fast and slow DIDS
binding processes are independent of Ca21 and that the fast
DIDS binding mechanism only affects RyR activity in the
presence of Ca21.
Multi-step, nonreversible activation
Single-channel recordings from ten experiments reveal that
fast and slow DIDS activation are multi-step binding pro-
cesses involving the binding of several DIDS molecules.
Individual RyRs would progressively activate during several
minutes of sustained exposure to low [DIDS]. Fast activation
could be seen to proceed in distinct steps. A representative
example of three identical experiments is shown in Fig. 7 A.
The trace in this ﬁgure commences when 1 mM DIDS was
rapidly perfused onto the RyR (ﬁrst arrow) in the presence of
100 mM Ca21. The activity of the RyR remained unaffected
FIGURE 6 The time course of DIDS induced nonreversible activation of RyRs. (A) RyRs were repeatedly exposed to 500 mM DIDS for periods lasting
5–60 s. The progressive, nonreversible activation was measured using the experimental protocol shown in Fig. 3 A. The mean Po is plotted against total DIDS
exposure time. The curves show exponential ﬁts to each time course. In the absence of cytoplasmic Ca21, DIDS activated RyRs with a time constants of 486
13 s (6, 50) (no ATP) and 936 36 s (10 mMATP) (7, 15) and in the presence of 10 mMCa21, 126 6 s (8, 126). (B) The activation of;15 RyRs in response to
1 mMDIDS (applied at the arrow) in the presence of 100 mM Ca21. Activation showed a marked latency that was much longer than any delay expected from
solution exchange (;1 s). (C) 12 RyRs in the presence of 3 mMCa21were exposed to 10 mMDIDS (arrow) which activated the RyRs to a steady level for the
following 90 s. Subsequently increasing [DIDS] to 500 mM caused an immediate increased in RyR activity which was not completely reversed by returning to
10 mM DIDS. (D) 15 RyRs, initially in 100 mM Ca21, were perfused with solution with 1 nM Ca21 (solid bar). During this time the RyRs were exposed to
1 mM DIDS (open bar) which does not signiﬁcantly activate RyRs under these conditions (see A). However, returning [Ca21] to 100 mM reveals that DIDS
has alteredRyRactivity. The current spikes that occurred during the [Ca21] steps are due toCa21 activation ofRyRs as the [Ca21] passed through the range 1–100
mM. Approximate scales for mean open probability (Po) of the RyRs are shown at the right of panels B–D. Numbers in parentheses represent the numbers of
channels and experiments, respectively.
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for ;40 s after the addition of DIDS and then it appeared to
abruptly enter a new, more active mode of activity (second
arrow). This occurred again at ;60 s further into the record
(third arrow). In a separate experiment, the stepwise in-
crease in channel activity could be arrested during inter-
mediate phases by removingDIDS from the bath (not shown).
Frequency distributions of open and closed dwell times, com-
piled from several sections within each phase, showed
that channel activity was indeed stationary within these
sections. This is shown in Fig. 7, B and C for the data in
Phase 2 where the length of the error bars shows variations
in dwell-time distributions occurring within this section.
Thus there are several phases to the DIDS modiﬁcation of
RyRs, which can be identiﬁed by different levels of activity.
Frequency distributions of RyR gating in Phase 1 are not sig-
niﬁcantly different from that of native RyRs. Phase 2 is
marked by order of magnitude increases and decreases in
mean open and closed times, respectively. Similar changes
in open and closed times again marked the progression
into Phase 3 of RyR activation. The mean duration and Po
of the three phases of activation from the three experi-
ments were: Phase 1– 28 6 9 s, 0.08 6 0.06; Phase 2– 53
6 14 s, 0.39 6 0.03 and Phase 3– Po ¼ 0.87 6 0.02.
Progressive activation due to the slow DIDS mechanism
was analyzed in four experiments where RyRs were
exposed to 10 mM DIDS in the absence of Ca21 (;1 nM).
The stepwise increments in RyR activation were present
but were not as clearly deﬁned as those seen in Fig. 7 A.
The mean duration and Po of the four segments of
activation were: Phase 1– 56 6 11 s, (1.6 6 0.5) 3 104,
Phase 2– 65 6 16 s, (7 6 2) 3 104, Phase 3– 260 6 140
s, (4.5 6 2.7) 3 103 and Phase 4– Po ¼ (4.0 6
0.5) 3 102.
Competition experiments
with nonreversible activation
We investigated the possibility that reversible and non-
reversible activation was due to DIDS binding to a common
set of sites on the RyR. One could imagine that DIDS ﬁrst
interacts with the RyR with weak binding and then after
some time cross-links with available amino acid residues to
form a covalent bond. If this were the case then reversible
DIDS activation should not be apparent in DIDS modiﬁed
RyRs. Furthermore, suramin,DBDS, andDNDS,which com-
pete with DIDS for reversible sites, should also protect the
RyR from nonreversible DIDS binding. With regard to the
former, we found that after short exposures to 500 mM
FIGURE 7 Nonreversible activation of RyRs by DIDS occurs in several phases. (A) A single RyR is activated by 1 mMDIDS. The ﬁrst arrow indicates the
time when DIDS was applied to the RyR by fast perfusion. The second and third arrows mark abrupt increases in Po. These arrows delineate three apparent
phases of channel activation labeled 1 to 3. The Po values of the RyRs during Phases 1 to 3 were 0.028, 0.4, and 0.86, respectively. (B) Open and (C) closed
dwell-time distributions from the three phases of channel activation inA plus the control conditions before addition of DIDS. To show the stationarity of gating
in Phase 2, dwell-time data were compiled from the ﬁrst and second halves of this section. Vertical bars through the data indicate the difference in the
distributions. The recording was ﬁltered at 5 kHz and sampled at 50 kHz. Channel openings are upward transitions form the baseline (dashed line). The data are
plotted using logarithmically spaced bins as described by Sigworth and Sine (1987).
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DIDS, DIDS could still produce a small reversible increase
in RyR activity in the presence of 1 mM Ca21 (e.g., see
Fig. 3, B and C). Even after 3–9 min exposure to 500 mM
DIDS, the presence of 500 mMDIDS reversibly activated the
DIDS modiﬁed RyRs from 0.29 6 0.03 to 0.61 6 0.03
(4 experiments on 14 channels). This result indicates that
slow, nonreversible activation and reversible activation are
associated with different DIDS binding sites on the RyR.
The effect of suramin and DBDS on nonreversible DIDS
activation of RyRs is shown in Fig. 8. In the presence of
a very high concentration of suramin (Fig. 8 A) or DBDS
(Fig. 8 B), RyRs were exposed to 1 mM DIDS for ;30 s.
Suramin at 1 mM (203 Ka(suramin), see Table 2) should slow
the onset of DIDS activation by 20-fold if suramin and DIDS
share common binding sites. However, DIDS exposure in
the presence of suramin had the same effect as normally seen
in the absence of suramin; demonstrating that suramin does
not impede activation by DIDS. Similar experiments using
500 mM DBDS (3 3 Ka(DBDS)) instead of suramin gave the
same ﬁnding. Therefore different binding sites are associated
with the reversible and fast nonreversible mechanisms.
Nonreversible activation and ATP binding
We investigated the possibility that DIDS activated RyRs by
covalently binding to the nucleotide activation sites on the
RyR. This was tested by exposing RyRs to DIDS in the
presence of high concentrations (10 mM, 30 3 Ka(ATP)) of
ATP and then seeing if ATP slowed the progression of
nonreversible activation by DIDS. The exponential time
constant of nonreversible DIDS activation of RyRs in the
presence of ATP (Fig. 6 A) was 93 6 36 s which was not
signiﬁcantly different to that in the absence of ATP (48 6
13 s). Thus ATP had no protective effect against slow DIDS
activation observed in the absence of Ca21. In analogous
experiments to those shown in Fig. 8 (not shown), ATP did
not prevent fast, nonreversible activation by 1 mM DIDS in
the presence of 1 mMCa21. These ﬁndings indicate that both
the fast and slow DIDS activation sites are distinct from the
ATP binding sites on the RyR.
Ligand regulation of DIDS modiﬁed RyRs
We explored the ligand regulation of RyRs that had been
modiﬁed by the covalent binding of DIDS. DIDS modiﬁca-
tion was achieved by incubating RyRs for periods of 1 and 4
min. The comparative effects of DIDS modiﬁcation after
these exposure times indicated whether channel modiﬁca-
tion was due to fast or slow DIDS activation mechanisms.
DIDS was then washed away before channel activity was
measured. A summary of the regulation of DIDS-modiﬁed
RyRs by Ca21, Mg21, ATP, and pH is shown in Fig. 9. This
is compared with the regulation of native RyRs measured in
previous studies from this laboratory. Table 3 lists the key
parameters from theoretical ﬁts to the data from native and
DIDS-modiﬁed RyRs.
The Ca21 regulation of RyRs was strongly affected by
covalent DIDS modiﬁcation (Fig. 9 A). DIDS activated
RyRs over the entire experimental range of cytoplasmic
FIGURE 8 High concentrations of suramin or DBDS do not protect RyRs
from fast DIDS activation. (A) Four RyRs in the presence of 1 mM Ca21 are
exposed to 1 mM suramin (solid bar). During this time the RyRs are exposed
to 1mMDIDS for;30 s (open bar). In the presence of suramin DIDS further
activated the RyRs and activity did not return to control levels after the
removal of DIDS and suramin. (B) Effects of DBDS and DIDS on a single
RyR shown in consecutive traces. The top three traces demonstrate reversible
activation by DBDS alone. Traces 4–8 show that 20 s DIDS exposure in the
presence of DBDS causes nonreversible activation. In these experiments
channel openings produce upward current jumps from the baseline (dashed
line). Approximate scales for mean Po are shown at the right of A.
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[Ca21]. The bell-shaped Ca21 dependence, characteristic of
native RyRs, was still apparent after DIDS treatment. RyR
sensitivity to Ca21 activation was not signiﬁcantly affected.
However, Ca21 inhibition was shifted by an order of
magnitude to higher [Ca21] and there was a large component
of channel activity that did not require Ca21. The rates of
DIDS activation, shown in Fig. 6, were determined at
[Ca21] ¼ 1 nM (Fig. 6 A), 3 mM (Fig. 6 C), 100 mM
(Fig. 6 B) and 10 mM (Fig. 6 A). These results indicate that
modiﬁcation of the Ca21-independent part of the Ca21 de-
pendence ([Ca21]\1 mM) is associated only with the slow
DIDS activationmechanismwhereasmodiﬁcation of the bell-
shaped part is primarily associated with the fast mechanism.
We noted that the slow DIDS binding process did have
a minor activating effect on RyRs at high [Ca21]. In the
presence of 500 mM DIDS, RyR activation by the fast
mechanism should have been very fast (;10 ms). However,
sustained application of 500 mM DIDS from 20 s to120 s
exposure times further increased RyR activity by 25% 6
15% (n ¼ 5).
Mg21 inhibition of DIDS modiﬁed RyRs is shown in Fig.
9 B. In the presence of 1 mM [Ca21], Mg21 inhibited RyRs
FIGURE 9 Regulation of DIDS modiﬁed and native RyRs by cytoplasmic Ca21, Mg21, ATP, and pH. Also shown are theoretical ﬁts to the data from DIDS
modiﬁed RyRs (solid curves) and from native RyRs obtained previously (dashed lines, the original data have been omitted for clarity). (A) Regulation by
cytoplasmic Ca21 (20, 95) of RyRs exposed to 100 mMDIDS for 3–4 min. (B) Mg21 inhibition in the presence of 1 mM Ca21 (2, 30) of RyRs exposed to 100
mM DIDS for 1 min. (C) ATP activation in the absence of Ca21 (5, 83) of exposed to 100 mM DIDS for either 1 or 4 min. One minute incubation with DIDS
produced relatively little activation reﬂecting the low rate of DIDS activation. (D) Inhibition by low pH in the presence of 100 mM Ca21 (6, 20) of RyRs
exposed to 100 mMDIDS for either 1 or 4 min. pH was buffered using 5 mM TES and 5 mMMES (2-[N-Morpholino]ethane-sulfonic acid). RyRs. DIDS had
no signiﬁcant effect on pKi but did produce a signiﬁcant but small increase in RyR activation at pH below 6.5. The parameters for the ﬁtted curves are listed in
Table 3 and the sources for the native RyR data are listed in the Table caption. The arrows indicate speciﬁc RyR properties that are modiﬁed by fast (F) and
slow (S) DIDS mechanisms. Upper case labels indicate major contributions by fast and slow mechanism and lower case symbols indicate minor contributions.
Numbers in parentheses represent the numbers of channels and experiments, respectively.
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with an effective Ki of 7.5 mM. Thus, DIDS modiﬁed RyRs
were 10-fold less sensitive to Mg21 inhibition than native
ones and modiﬁcation of Mg21 inhibition occurred in less
than 1 min and so was likely to be associated with the fast
DIDS process. As yet we have not determined whether the
slow process contributes to modiﬁcation of Mg21 inhibition.
DIDS produced substantial activation of ATP activated
RyRs after 4 min exposure (Fig. 9 C). DIDS increased Po by
;0.4 over the entire experimental range of [ATP] (0–8 mM)
but did not signiﬁcantly alter the ATP sensitivity, Ka(ATP), of
the RyR (see Table 3). DIDS exposures of only 1 min had
relatively little effect on the ATP activation properties of
RyRs indicating that the effect of DIDS was primarily a result
of the slow DIDS modiﬁcation process.
Similarly, DIDS had no signiﬁcant effect on the sensitivity
of RyRs to inhibition by low pH (Fig. 9 D). In addition to
RyR activation at high pH (see above) DIDS caused a small
but signiﬁcant increase in RyR activity at low pH which was
only apparent after 4 min exposures to DIDS. Thus it appears
that this effect is due to the slow DIDS modiﬁcation process.
DISCUSSION
The experimental ﬁndings indicate that DIDS can activate
RyRs by one reversible and two nonreversible mechanisms,
each associated with DIDS binding at different sites on
the RyR complex. The two nonreversible mechanisms are
distinguished by their disparate DIDS binding rates and the
different effects they exert on RyRs. The faster mechanism
confers a DIDS sensitivity to RyRs that is 3 orders of
magnitude greater than previously thought (e.g., Hirata et al.,
1999; Sitsapesan, 1999). DIDS, DBDS, and DNDS may all
share a common reversible activation mechanism.
Mechanism for reversible activation
Reversible activation by suramin and DBDS can produce
near maximal activity (Po ; 0.8) of RyRs in the absence of
Ca21 and ATP and at high concentrations of Ca21 and Mg21
where RyRs are normally inactive. Klinger et al. (1999),
Sitsapesan (1999) and Sitsapesan and Williams (1996) have
seen similar levels of activation by suramin.
Suramin and DBDS produce the same effects on RyR
conductance (Hill and Sitsapesan, 2002; Sitsapesan, 1999).
We show that disulfonated stilbenes and suramin have
a number of other features in common. The activating effects
of these compounds decrease with decreasing cytoplasmic
Ca21 and with increasing amounts of negatively charged PS
in the lipid bilayer (see below). This further supports the
hypothesis (see Sitsapesan, 1999) that suramin and DBDS
bind at common sites on the RyR.
The number of reversible binding sites on each RyR is not
certain but theHill coefﬁcients indicate thatmore than one site
is involved in the reversible activation process. This is
expected because as the RyR has a homotetrameric structure
that can have four copies of each binding site. The effect of
lipid headgroup charge on DIDS, DBDS, and suramin
binding implies that these binding sites are in close proximity
to the bilayer surface. Electrostatic repulsion between these
compounds and the lipid headgroups is a relatively short
range interaction because of charge screening by mobile ions
in the bath. Therefore a binding site on the RyR that is more
than;1 nm from themembrane (the Debye length in 250mM
monovalent electrolyte) will not be signiﬁcantly affected by
charge on the lipid headgroups. It is also unlikely that the
binding sites lie within the bilayer itself because these
compounds are unable to permeate the bilayer and activate
RyRs from the luminal side (Sitsapesan andWilliams, 1996).
The fact that suramin, DBDS, and DIDS can bind to the lipids
opens up the possibility that the lipid headgroups form part of
their binding pocket. This is supported by the fact that the
apparent afﬁnities for adsorption of these compounds to lipid
bilayers matches that for their activating effects on RyRs.
It is unlikely that the lipids confer the Ca21 dependence on
reversible activation because DIDS adsorption to lipids was
not dependent on [Ca21] over the range 0–1 mM (Fig. 2 C).
TABLE 3
Parameter
DIDS modiﬁed
RyRs Native RyRs
Ca21 regulation
Ka(Ca) 4 6 2 mM 1.0 6 0.7 mM
Ki(Ca) 9.3 6 2.2 mM 0.71 6 0.08 mM
na(Ca) 1.2 6 0.5 1.3 6 0.5
ni(Ca) 1.2 6 0.3 2.2 6 0.2
Pmax(Ca) 0.71 6 0.07 0.5 6 0.15
Pi(Ca) 0.44 6 0.11 0
Mg21 inhibition
Ki(Mg) at
1 mM Ca21
7.5 6 2.8 mM 0.49 6 0.07 mM
ni(Mg) at
1 mM Ca21
1.5 6 0.4 1.9 6 0.2
ATP activation
Ka(ATP) 0.32 6 0.04 mM 0.36 6 0.08 mM
na(ATP) 2.6 6 0.4 1.8 6 0.7
Pmax(ATP) 0.91 6 0.04 0.33 6 0.04
Pi(ATP) 0.54 6 0.11 0
Low-pH inhibition
DIDS exposure RyR activated by:
1 min 4 min (5 mM ATP) (50 mM Ca21)
pKi 6.7 6 0.03 6.67 6 0.02 6.7 6 0.2 6.6 6 0.1
na(pH) 4 6 2 2.8 6 0.3 2.0 6 0.4 2.6 6 0.2
Pmax(pH) 0.8 6 0.1 0.67 6 0.03 0.48 6 0.02 0.07 6 0.02
Pi(pH) 0 6 0.001 0.025 6 0.002 0 6 0.001 0 6 0.001
Parameters used for the theoretical curves in Fig. 9 (see Eqs. 1 and 2). Pmax
and Pi are the RyR open probabilities at maximally activating ligand
concentration and in the absence of ligands, respectively. na, nI, and Ka are
the Hill coefﬁcient and apparent afﬁnity for activation, respectively, and ni
and Ki are corresponding parameters for inhibition. pKi is the pH for half
inhibition. Parameters obtained for native RyRs were obtained from Laver
et al. (1995, 1997) for Ca21 regulation, Laver et al. (1997) for Mg21
inhibition, Laver et al. (2001) for ATP activation and Laver et al. (2000) for
pH inhibition.
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It is more likely that the disulfonated stilbenes and suramin
act synergistically with Ca21 to activate RyRs in a manner
similar to that known for adenine nucleotides and Ca21
(Meissner, 1994). The Ca21 dependence of reversible
activation seen here for DBDS (c.f. Fig. 5, A and C) is
similar to that reported previously for suramin. At sub-
micromolar [Ca21] the suramin dose response is strongly
sigmoidal with half activation concentrations in the range
200–2000 mMwhile in the presence of 5–100 mMCa21, half
activation occurs at ;50 mM (Hohenegger et al., 1996;
Klinger et al., 1999; Suko et al., 2001).
Several studies have focused on determining if suramin
activates RyRs by binding at the adenine nucleotide
activation sites on the RyR (see introduction). Biochemical
(Hohenegger et al., 1996) and functional assays (Sitsapesan
and Williams, 1996) show that ATP and suramin bind at
different sites on the RyR. We conﬁrmed this hypothe-
sis with an alternative functional assay to that used by
Sitsapesan and Williams (1996) in which we measured the
effect of adenosine on suramin activated RyRs. Adenosine is
known to inhibit ATP-activated RyRs by competing with
ATP (Laver et al., 2001). However, in the presence of
suramin, adenosine was a RyR activator, clearly demon-
strating that adenosine does not compete with suramin for
a common activation site.
Two nonreversible activation mechanisms
Two mechanisms underlying nonreversible activation could
be distinguished by the 1000-fold difference in their rate of
onset. The apparent binding rates were 105 M1 s1and
60 M1 s1 for the fast and slow mechanisms, respectively.
Thenonreversible and reversiblemechanismsare independent
because as their activation effects are additive, and DBDS
and suramin did not inhibit DIDS activation (Fig. 8). Fast
and slow mechanisms are also independent of each other and
they are associated with DIDS binding which is independent
of [Ca21]. These DIDS binding sites are unlikely to be
the ATP activation binding sites because ATP and DIDS
activation were additive and ATP did not inhibit DIDS ac-
tivation (either fast or slow).
Both mechanisms activated the RyRs in several stages that
were distinguished by step changes in RyR open probability.
The stages of activation referred to here should not be
confused with a similar phenomenon reported by Sitsapesan
(1999), in which RyRs were initially activated reversibly
and subsequently modiﬁed by covalent DIDS binding. In
our study, [DIDS] was kept low when observing stepwise
activation to avoid signiﬁcant reversible activation. The mul-
tiple stages of activation reveal the complexity of the DIDS
activation mechanism. It is likely that a DIDS binding event
initiates each stage of the activation sequence because in-
creasing [DIDS] speeds activation through all stages and
DIDS removal arrests further activation. However, it is not
clear whether the multiplicity of binding events is due to
DIDS binding at single or multiple sites on each subunit of
the RyR. DIDS binding at a single site on each subunit could
produce four stages of activation, each corresponding to
a different number of covalently modiﬁed subunits.
The two nonreversible mechanisms have different effects
on the RyRs. Slow activation is near maximal after ;4 min
of exposure to 100 mMDIDS but has relatively little effect at
less than 1 min exposure. An example of slow activation can
be seen in Fig. 3 A. The slow mechanism 1) activates RyRs
in the absence of Ca21 and ATP, 2) activates RyRs in the
presence of ATP without altering Ka(ATP), 3) produces minor
activation of RyRs at inhibiting pH levels (i.e., pH less than
6.5) without altering pKi, 4) makes a minor contribution to
the activation of Ca21 activated RyRs. Fast activation of
RyRs is more speciﬁc in its effect on RyR gating. Here it only
modiﬁed the Ca21/Mg21 regulation of the channel. Fast
activation increases the maximal Po of Ca
21 activation from
0.45 to 0.71, and causes a 10-fold decrease in RyR sensitivity
to Ca21/Mg21 inhibition. The fast mechanism was not re-
ported in previous studies (Sitsapesan, 1999; Zahradnikova
and Zahradnik, 1993) where DIDS was applied in aliquots
with bath stirring. In our study we were also unable to resolve
fast activation when using this method of DIDS application.
The precise reason for the pronounced latency in the
activation time course at low [DIDS] is not known. The
latency indicates that there is a relatively slow, [DIDS]-
dependent reaction step somewhere in the activation process
that does not produce immediate activation of the RyRs. This
reaction step could either be limited access of DIDS to the
RyR, or a DIDS binding event that leaves RyR activity
unaffected. Though we cannot completely rule out the
possibility of limited access we feel it is unlikely because
RyRs respond reversibly to DIDS and the other compounds
in less than 1 s. We considered the possibility that adsorption
of DIDS to the lipid bilayer temporarily siphons DIDS away
from the RyRs. However, the DIDS buffering capacity of the
lipid bilayer is not high enough to signiﬁcantly lower the
DIDS concentration near the RyR for more than a few
milliseconds after the onset of perfusion. The more likely
scenario is that there is a delay, for some reason, between in
the ﬁrst DIDS binding event and the onset of RyR activation.
General signiﬁcance
The increased multiplicity of DIDS activation mechanisms
gives new insights into RyR function and also provides an
explanation of controversies in the literature. For example,
Hirata et al. (1999) propose that DIDS modiﬁes RyRs by
binding to a 30 kDa coprotein on the cytoplasmic side of the
membrane. They did not detect DIDS binding to the RyR at
all. However, DIDS modiﬁcation of puriﬁed cardiac RyRs
(Hill and Sitsapesan, 2002) clearly demonstrates that DIDS
can bind directly to the RyR. These contradictory inter-
pretations could be reconciled if the conﬂicting experiments
were measuring different mechanisms. Hirata et al. (1999)
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experiments that used low [DIDS] (3 mM) would have only
detected the fast mechanism, and Hill and Sitsapesan (2002)
study, using high [DIDS] (1 mM) would observed the
combined effects of the fast and slow mechanisms.
Both DIDS and DBDS increased RyR conductance to K1
and Ca21 (Hill and Sitsapesan, 2002). These effects were
reversible in the short term and nonreversible in the long
term. Thus conductance modiﬁcation occurs at sites that can
bind DIDS reversibly and nonreversibly. The DIDS binding
sites identiﬁed by Hill and Sitsapesan (2002) for cardiac
RyRs must be different to those identiﬁed in skeletal RyRs in
this study because the reversible and nonreversible mecha-
nisms here are independent.
The actions of DIDS reported here reveal new ways that
DIDS might elucidate RyR function. For example, the fact
that the fast DIDS mechanism modiﬁes Ca21-dependent
gating and not ATP-dependent gating indicates that the
transduction of Ca21 and ATP binding into channel opening
occurs via different molecular pathways. Also, the stepwise
activation of RyRs by DIDS is consistent with the coop-
erative molecular events in the four subunits of the RyR
homotetramer that lead to gating of the pore.
The high sensitivity and functional speciﬁcity for fast
activation are attributes that favor the use of DIDS-based
compounds as therapeutic agents for enhancing Ca21-
induced Ca21 release from the SR of skeletal and cardiac
muscle. Indeed, DIDS at relatively low concentrations has
already proved beneﬁcial in protecting ischemic myocar-
dium (Ramasamy et al., 2001). Finally, the marked effect of
membrane lipids on the pharmacology of RyRs has not been
reported before and it conﬁrms that functional interactions
occur between membrane proteins and the cell membranes in
which they are embedded.
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